We recently published a list of These 10 Stocks Posted Double-, Triple-Digit Gains Last Week. In this article, we are going ...

CervoMed Inc. (CRVO) shares ended the last trading session ... stocks here >>>> CERVOMED INC is part of the Zacks Medical - Biomedical and Genetics industry. Cellectis S.A. (CLLS), another stock ...

In this article, we will see how CervoMed Inc. (NASDAQ:CRVO) compares to the other top short squeeze stocks that have received a Buy rating from analysts. Stock market trading has an ever-changing ...

Shares of CRVO opened at $7.71 on Wednesday. The company has a 50-day moving average of $3.72 and a two-hundred day moving average of $7.68. The stock has a market cap of $67.10 million, a price ...

In this article, we are going to take a look at where CervoMed Inc. (NASDAQ:CRVO) stands against other best short-term stocks with a buying opportunity for investors. Thrilling highs, daunting ...

Reported positive 16-week results from the extension phase of the Phase 2b RewinD-LB trial of neflamapimod in dementia with Lewy bodies (DLB), including improvement on the trial’s primary outcome ...

CervoMed (NASDAQ:CRVO – Get Free Report) had its target price lifted by equities research analysts at Canaccord Genuity Group ...

CervoMed Inc. has announced that it will present at the 19th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurologic Disorders in Vienna, Austria, from April 1 ...